Status:
COMPLETED
Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ Patients
Lead Sponsor:
Cimera
Collaborating Sponsors:
Hospital Universitari Son Dureta
Conditions:
HIV Infections
COPD
Eligibility:
All Genders
40-69 years
Brief Summary
The prevalence of COPD in HIV+ and AIDS patients is unknown. The pathophysiology of HIV infection and COPD might be of interest to both conditions. The research hypotheses of this study are: In patie...
Detailed Description
Objectives Main objective To determine the prevalence of COPD Secondary objectives 1. To determine the prevalence (and severity) of emphysema (HRCT) 2. To Identify risk factors associated with the ...
Eligibility Criteria
Inclusion
- HIV infection in stable phase (minimum of three months)
- Being followed-up in external HUSD consultations (on a regular basis)
- Age 40-69 years
Exclusion
- Chronic non-respiratory disease in terminal stage (stage IV or V of chronic kidney failure, heart failure, advanced chronic liver disease (Child C))
- Lack of cooperation
- Estimated survival of less than 1 year or Karnofsky \<70
- Pregnancy
- Opportunistic infection in the last month
- Post lung resection
- Systemic treatment with corticosteroids, immunosuppressive chemotherapy or interferon at the time of inclusion
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2011
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00904384
Start Date
July 1 2008
End Date
January 1 2011
Last Update
June 10 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Son Dureta
Palma de Mallorca, Balearic Islands, Spain, 07014